11 alpha-bromoacetoxyprogesterone has been researched along with nad in 2 studies
| Studies (11 alpha-bromoacetoxyprogesterone) | Trials (11 alpha-bromoacetoxyprogesterone) | Recent Studies (post-2010) (11 alpha-bromoacetoxyprogesterone) | Studies (nad) | Trials (nad) | Recent Studies (post-2010) (nad) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 30,121 | 88 | 5,663 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boussioux, AM; Chikhaoui, Y; Crastes de Paulet, A; Descomps, B; Nicolas, JC | 1 |
| Nash, WE; Strickler, RC; Thomas, JL | 1 |
2 other study(ies) available for 11 alpha-bromoacetoxyprogesterone and nad
| Article | Year |
|---|---|
Active site-directed irreversible inhibition of 3 beta-hydroxysteroid dehydrogenase from human placenta.
Topics: 3-Hydroxysteroid Dehydrogenases; Alkylation; Dehydroepiandrosterone; Female; Humans; Hydrogen-Ion Concentration; Hydroxyprogesterones; Kinetics; NAD; Placenta; Pregnancy | 1983 |
Physiological 3 beta-hydroxy-5-ene steroid substrates bind to 3 beta-hydroxysteroid dehydrogenase without the prior binding of cofactor.
Topics: 3-Hydroxysteroid Dehydrogenases; Enzyme Activation; Humans; Hydroxyprogesterones; Hydroxysteroids; NAD; Placenta; Substrate Specificity | 1996 |